Home/Researchers & Academics
For Researchers & Academics
Turn discovery into impact —
without leaving your mission behind.
You have made a discovery that could change the world. PIPE provides the structured commercial pathway to get it there — protecting your IP, respecting your timeline, and doing the heavy lifting on commercialisation so you can focus on the science.
Frequently Asked Questions
Your questions,
answered.
Will submitting to PIPE affect my ability to publish or patent?
No. The PIPE disclosure process is specifically designed to protect both patent potential and publication timelines. You never disclose the inventive step — the assessment is conducted on the basis of context, problem statement, and application area. Your TTO is involved at every stage, and no commercial engagement occurs without your explicit consent.
Do I have to leave my academic role to commercialise through PIPE?
No. PIPE Associates handle the commercial pathway — from market validation and investor engagement to venture formation and IP structuring. You choose the level of involvement that works for you, from occasional advisory input to active founding role. Many researchers remain fully in post throughout.
What happens if my project does not pass the Go/No-Go assessment?
You receive a detailed report explaining the assessment findings — including what factors contributed to the decision and, where applicable, what changes could improve commercial viability. This feedback is confidential and is shared only with you and your TTO. There is no cost to you for the initial assessment.
Who owns the IP? What equity do I receive?
IP ownership arrangements are agreed with your institution and formalised before any commercial engagement begins. PIPE operates within your institution's standard IP framework. Researcher equity participation is structured on a project-by-project basis and is always documented transparently before you commit to proceeding.
Is there a cost to submit an innovation?
Registration and initial submission are free. The Go/No-Go assessment is provided at no direct cost to the researcher — PIPE's commercial model is based on shared value creation at later stages, not upfront fees from individuals.